Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Prime Doctor RX

CoreAge Rx
Graded #1

Higher grade

vs+18.8
Prime Doctor RX
Graded #84

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 73/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +30
92
62
Dose & formulationCoreAge Rx +6
88
82
Clinical oversightCoreAge Rx +13
93
80
Labs & monitoringCoreAge Rx +12
90
78
FulfillmentCoreAge Rx +23
95
72
Contract termsCoreAge Rx +36
96
60
CoreAge Rx · left barPrime Doctor RX · right bar

The numbers

MetricCoreAge RxPrime Doctor RX
WeighScore91.8/10073/100
GradeA−C
Scorecard rank#1#84
Semaglutide$99/mo$249 every 4 weeks (thirteen charges a year, not twelve)
Tirzepatide$149/mo$339 every 4 weeks (thirteen charges a year, not twelve)
CoverageAll 50 statesNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
Prime Doctor RX

Graded #84 · C

Strengths

  • The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
  • The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
  • The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
  • Names OpenLoop Health as the group providing telehealth evaluation and prescribing
  • Hormone-care initial labs are priced at $50 rather than left unstated

Where it loses points

  • Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
  • A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
  • The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
  • The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
  • The $50 lab fee sits in a "how it works" step rather than in the pricing table

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard